Skip to main navigation
  • Skip to main content
  • Skip to footer
Scholar Rock

Scholar Rock - Utility Menu

  • Careers
  • Contact Us

Main navigation

  • Our Company
    • Management Team
    • Board of Directors
    • Partnering
    • Learn About Our Company
  • Our Science
    • Structural Insights & the Growth Factor Precursor
    • Platform
    • Publications & Posters
    • Learn About Our Science
  • Our Pipeline
    • Spinal Muscular Atrophy
    • Oncology
    • Fibrosis
    • Iron-Restricted Anemia
    • Clinical Trials
    • Learn About Our Pipeline
  • Patients & Families
  • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Committee Composition
      • Management Team
      • Board of Directors
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR

Breadcrumb

Home / Investors & Media / Investors & Media / Press releases

Press releases

Explore Investors & Media

  • Investor Overview
  • Press Releases
    • Archived Press Releases
  • Events & Presentations
  • Corporate Governance
    • Committee Composition
    • Management Team
    • Board of Directors
  • Financials & Filings
    • SEC Filings
  • Stock Information
    • Historical Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Contact IR

October 27, 2020

Scholar Rock Announces Proposed Public Offering of Common Stock

Read This Press Release

October 27, 2020

Scholar Rock Announces Positive Proof-of-Concept Data from TOPAZ Phase 2 Trial Interim Analysis of SRK-015 in Patients with Type 2 and Type 3 Spinal Muscular Atrophy

Read This Press Release

October 19, 2020

Scholar Rock Secures $50 million Debt Facility with Silicon Valley Bank and Oxford Finance

Read This Press Release

September 30, 2020

Scholar Rock Presents Data for SRK-015 at the World Muscle Society 2020 Virtual Congress

Read This Press Release

September 9, 2020

Scholar Rock Announces First Patient Dosed in Part A2 of DRAGON Phase 1 Proof-of-Concept Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy

Read This Press Release

September 2, 2020

Scholar Rock to Present at Upcoming Healthcare Conferences

Read This Press Release

August 27, 2020

Scholar Rock Announces Issuance of U.S. Patent Providing Composition of Matter Protection for SRK-015

Read This Press Release

August 13, 2020

Scholar Rock Announces that SRK-015 has Received Rare Pediatric Disease Designation from U.S. FDA for the Treatment of Spinal Muscular Atrophy

Read This Press Release

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »
Archived Press Releases
  • RSS Feeds
  • Search

Footer

SCHOLAR ROCK
620 Memorial Dr 2nd Floor
Cambridge, MA 02139

MOVING EARLY 2021 TO
301 Binney Street, 3rd Floor
Cambridge, MA 02142

Phone: 857.259.3860
info@scholarrock.com

Contact Us

LinkedIn Twitter

Scholar Rock - Main navigation

  • Our Company
    • Management Team
    • Board of Directors
    • Partnering
    • Learn About Our Company
  • Our Science
    • Structural Insights & the Growth Factor Precursor
    • Platform
    • Publications & Posters
    • Learn About Our Science
  • Our Pipeline
    • Spinal Muscular Atrophy
    • Oncology
    • Fibrosis
    • Iron-Restricted Anemia
    • Clinical Trials
    • Learn About Our Pipeline
  • Patients & Families
  • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Committee Composition
      • Management Team
      • Board of Directors
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR
  • Community Guidelines
  • Expanded Access Policy
  • Terms of Use
  • Privacy Policy

Scholar Rock, Inc. © 2021 All Rights Reserved

    Scholar Rock - Main navigation

  • Our Company
    • Management Team
    • Board of Directors
    • Partnering
    • Learn About Our Company
  • Our Science
    • Structural Insights & the Growth Factor Precursor
    • Platform
    • Publications & Posters
    • Learn About Our Science
  • Our Pipeline
    • Spinal Muscular Atrophy
    • Oncology
    • Fibrosis
    • Iron-Restricted Anemia
    • Clinical Trials
    • Learn About Our Pipeline
  • Patients & Families
  • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Committee Composition
      • Management Team
      • Board of Directors
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR
  • Scholar Rock - Utility Menu

  • Careers
  • Contact Us